Author Archive for: TG

The biotech company Actithera, with locations in Cambridge, USA, and Oslo, Norway, has successfully closed a major Series A round, raising US $75.5 million. Its isotope-agnostic platform — designed with a specific focus on the interaction between linker and target molecule — has attracted strong interest from a wide range of investors. However, the path to this achievement was not as straightforward as anticipated, CEO Andreas Goutopoulos told European Biotech News.

After Finnish protein powder producer Solarfoods signed a strategic agreement with two US food manufacturers to supply 6,000 tonnes of Solein from 2030 onwards, the company has now announced a more concrete partnership with US flavour manufacturer Sensapure Flavours Inc.

Biosimilar major Sandoz has started construction of an additional US$440m biosimilar facility near Ljubljana and it set to expand its investment footprint in Slovenia by US$1.1bn.

CDMO and filled syringe specialist Vetter has broken the ground for a new clinical site construction in the greater Chicago area that is expected to be ready for early clinical filling by the end of 2029. 

Final negotiations on proposed EU regulations for plants developed through genetic precision breeding have been delayed, following opposition from a group of MEPs in the European Parliament’s ENVI Committee. The group criticised the European Council and the European Commission for their inflexible stance on issues such as sustainability, labelling, and patent protection.